Ulf Landmesser
Inserm
3 papers in the Anchorcite directory, published between 2015 and 2020, cited 21,831 times in total.
ORCID profileResearch topics
- Acute Ischemic Stroke Management · 1 paper
- Atrial Fibrillation Management and Outcomes · 1 paper
- Cardiac Arrhythmias and Treatments · 1 paper
- Clinical practice guidelines implementation · 1 paper
- Pulmonary Hypertension Research and Treatments · 1 paper
- Vascular Anomalies and Treatments · 1 paper
Frequent co-authors
- Victor Aboyans · 2 papers
- Donna Fitzsimons · 2 papers
- Bernard Iung · 2 papers
- Jeroen Joost Bax · 2 papers
- Gregory Y.H. Lip · 2 papers
- Gerhard Hindricks · 1 paper
- Tatjana Potpara · 1 paper
- Isabelle C. Van Gelder · 1 paper
Papers
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)European Heart Journal · 2020 · 10,550 citations
Atrial fibrillation (AF) poses significant burden to patients, physicians, and healthcare systems globally. Substantial research efforts and resources are being directed towards gaining detailed information about the mechanisms underlying AF, its natural course and effective treatments (see also the ESC…
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Heart Journal · 2015 · 7,065 citations
Document Reviewers: Victor Aboyans (CPG Review Coordinator) (France), Antonio Vaz Carneiro (CPG Review Coordinator) (Portugal), Stephan Achenbach (Germany), Stefan Agewall (Norway), Yannick Allanore (France), Riccardo Asteggiano (Italy), Luigi Paolo Badano (Italy), Joan Albert Barbera (Spain), Helene Bouvaist (France), Hector Bueno…
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelEuropean Heart Journal · 2017 · 4,216 citations
AIMS: To appraise the clinical and genetic evidence that low-density lipoproteins (LDLs) cause atherosclerotic cardiovascular disease (ASCVD). METHODS AND RESULTS: We assessed whether the association between LDL and ASCVD fulfils the criteria for causality by evaluating the totality of evidence…
Metadata from OpenAlex (CC0).